Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of $167.49 million as of April 24, 2025. Its market cap has decreased by -11.39% in one year.

Market Cap

167.49M

Enterprise Value

110.97M

Revenue

20.83M

Ranking

n/a

PE Ratio

n/a

Stock Price

$1.45

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 1.01M to 167.49M, an increase of 16,454.71%. That is a compound annual growth rate of 31.83%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2025	167.49M	1.15%
Dec 31, 2024	165.58M	-29.08%
Dec 29, 2023	233.49M	-17.19%
Dec 30, 2022	281.97M	-29.50%
Dec 31, 2021	399.94M	19.60%
Dec 31, 2020	334.40M	-36.34%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SS Innovations International	1.66B
Endo Inc.	1.64B
Nika Pharmaceuticals	1.02B
Veradigm	704.15M
Elite Pharmaceuticals	437.70M
Northwest Biotherapeutics	402.62M
Glass House Brands	384.26M
CytoDyn	264.36M

Market Cap Rankings